Belousov E S, Afonina I A, Podyminogin M A, Gamper H B, Reed M W, Wydro R M, Meyer R B
Epoch Pharmaceuticals, Inc., 1725 220th Street SE, #104, Bothell, WA 98021, USA.
Nucleic Acids Res. 1997 Sep 1;25(17):3440-4. doi: 10.1093/nar/25.17.3440.
We compare two techniques which enable selective, nucleotide-specific covalent modification of human genomic DNA, as assayed by quantitative ligation- mediated PCR. In the first, a purine motif triplex-forming oligonucleotide with a terminally appended chlorambucil was shown to label a target guanine residue adjacent to its binding site in 80% efficiency at 0.5 microM. Efficiency was higher in the presence of the triplex-stabilizing intercalator coralyne. In the second method, an oligonucleotide targeting a site containing all four bases and bearing chlorambucil on an interior base was shown to efficiently react with a specific nucleotide in the target sequence. The targeted sequence in these cases was in the DQbeta1*0302 allele of the MHC II locus.
我们比较了两种技术,这两种技术能够实现对人类基因组DNA进行选择性、核苷酸特异性的共价修饰,通过定量连接介导的聚合酶链反应(PCR)进行检测。在第一种技术中,一种带有末端附加苯丁酸氮芥的嘌呤基序三链形成寡核苷酸,在0.5微摩尔浓度下,以80%的效率标记与其结合位点相邻的目标鸟嘌呤残基。在三链稳定嵌入剂珊瑚霉素存在的情况下,效率更高。在第二种方法中,一种靶向包含所有四种碱基的位点并在内部碱基上带有苯丁酸氮芥的寡核苷酸,被证明能与目标序列中的特定核苷酸有效反应。在这些情况下,靶向序列位于MHC II基因座的DQβ1*0302等位基因中。